Sign in
8-K

Current Report

Damora Therapeutics, Inc. Filed Acc 0001564590-21-013008

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading glto-8k_20210315.htm…